Atlas Trials

A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial

Clinical trial NCT06301308 · WITHDRAWN

Trial details

NCT number
NCT06301308
Sponsor
Second Xiangya Hospital of Central South University
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2023-10-01
Primary completion
2024-02-29
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.